Advertisement

India’s Covid-19 vaccine rollout needs to address hesitancy to truly take off

India’s Covid-19 vaccine rollout needs to address hesitancy to truly take off

India has kicked off the world’s largest Covid-19 vaccination programme, but the shadow of rushed approvals persists. Hesitancy over the safety and efficacy of Covaxin, India’s homegrown coronavirus vaccine developed by biotechnology firm Bharat Biotech and the Indian Council of Medical Research, has led to fewer people turning up for their shots. India began its vaccination drive for frontline and healthcare workers on Jan. 16, and has inoculated 631,417 people in four days.